🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHas anyone dealt with hypoglycemia risk with concomitant sulfonylurea use? Page 2

Has anyone dealt with hypoglycemia risk with concomitant sulfonylurea use?

ChrisMacros Fri, Feb 13, 2026 at 4:58 PM 6 replies 824 viewsPage 2 of 2
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Feb 13, 2026 at 6:07 PM#6

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

2 22JenMemphis, pat_auckland
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Feb 13, 2026 at 6:34 PM#7

Following on from PharmD_Rodriguez — and this may be the naive question:

What distinguishes the nausea you can titrate through from the nausea that means stop?

Last edited: Feb 13, 2026 at 8:34 PM
1 21Dr.RheumBOS
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Feb 13, 2026 at 7:01 PM#8
LabKate said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Adding the part of the answer the thread has not reached. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

50 20amsterdam_pete, LondonLisa, mike_nyc and 47 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Feb 13, 2026 at 7:28 PM#9

OP back with an update, since a thread like this is useless without one.

Update. It was not the dose, it was that I had stopped drinking anything because drinking made me feel full. Fixing that fixed most of it.

49 19LibrarianMeg, bri_stats, pete_manc_UK and 46 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Feb 13, 2026 at 9:39 PM#10
LindaRN_retired said:
Start from the measurement rather than the conclusion.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

37 10B12Beth, RickReta_CO, PharmHunterJen and 34 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register